These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33996546)

  • 1. Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer.
    Xiong L; Chen H; Tang X; Chen B; Jiang X; Liu L; Feng Y; Liu L; Li L
    Front Oncol; 2021; 11():621993. PubMed ID: 33996546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer.
    Park H; Lim Y; Ko ES; Cho HH; Lee JE; Han BK; Ko EY; Choi JS; Park KW
    Clin Cancer Res; 2018 Oct; 24(19):4705-4714. PubMed ID: 29914892
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
    Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
    Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
    Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
    Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics nomogram for predicting disease-free survival after partial resection or radical cystectomy in patients with bladder cancer.
    Cai Q; Huang Y; Ling J; Kong L; Lin Y; Chen Y; Cao W; Liao Y; Guo Y; Guan J; Wang H
    Br J Radiol; 2024 Jan; 97(1153):201-209. PubMed ID: 38263836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
    Zhang S; Song M; Zhao Y; Xu S; Sun Q; Zhai G; Liang D; Wu G; Li ZC
    Eur J Radiol; 2020 Oct; 131():109219. PubMed ID: 32905953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma.
    Xie D; Wang TT; Huang SJ; Deng JJ; Ren YJ; Yang Y; Wu JQ; Zhang L; Fei K; Sun XW; She YL; Chen C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1112-1123. PubMed ID: 32953490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
    Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
    Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 14. CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer.
    Fan S; Cui X; Liu C; Li X; Zheng L; Song Q; Qi J; Ma W; Ye Z
    Front Oncol; 2021; 11():644933. PubMed ID: 33816297
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
    Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
    Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound-based radiomics nomogram: A potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer.
    Yu FH; Wang JX; Ye XH; Deng J; Hang J; Yang B
    Eur J Radiol; 2019 Oct; 119():108658. PubMed ID: 31521878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.
    Xia B; Wang H; Wang Z; Qian Z; Xiao Q; Liu Y; Shao Z; Zhou S; Chai W; You C; Gu Y
    Front Genet; 2021; 12():783513. PubMed ID: 34868273
    [No Abstract]   [Full Text] [Related]  

  • 20. A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma.
    Ma X; Lv W; Wang C; Tu D; Qiao J; Fan C; Niu J; Zhou W; Liu Q; Xia L
    J Thorac Dis; 2022 Jan; 14(1):1-17. PubMed ID: 35242363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.